{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T03:07:39Z","timestamp":1771297659812,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","schres-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.schres.2017.05.006","type":"journal-article","created":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T23:46:06Z","timestamp":1494632766000},"page":"47-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["A method to achieve extended cannabis abstinence in cannabis dependent patients with schizophrenia and non-psychiatric controls"],"prefix":"10.1016","volume":"194","author":[{"given":"Rachel A.","family":"Rabin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina","family":"Kozak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantine K.","family":"Zakzanis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Remington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiana","family":"Stefan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan J.","family":"Budney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony P.","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.schres.2017.05.006_bb0005","doi-asserted-by":"crossref","first-page":"846","DOI":"10.2105\/AJPH.77.7.846","article-title":"Saliva cotinine as a measure of smoking status in field settings","volume":"77","author":"Abrams","year":"1987","journal-title":"Am. J. Public Health"},{"issue":"1\u20132","key":"10.1016\/j.schres.2017.05.006_bb0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.drugalcdep.2011.06.003","article-title":"The cannabis withdrawal scale development: patterns and predictors of cannabis withdrawal and distress","volume":"119","author":"Allsop","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.schres.2017.05.006_bb0015","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"APA","year":"2000"},{"issue":"1","key":"10.1016\/j.schres.2017.05.006_bb0020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/10826084.2014.958857","article-title":"Perceived harm, addictiveness, and social acceptability of tobacco products and marijuana among young adults: marijuana, hookah, and electronic cigarettes win","volume":"50","author":"Berg","year":"2015","journal-title":"Subst. Use Misuse"},{"issue":"2","key":"10.1016\/j.schres.2017.05.006_bb0025","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jpsychires.2012.10.010","article-title":"Cannabis withdrawal in chronic cannabis users with schizophrenia","volume":"47","author":"Boggs","year":"2013","journal-title":"J. Psychiatr. Res."},{"issue":"9","key":"10.1016\/j.schres.2017.05.006_bb0030","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1046\/j.1360-0443.1999.94913114.x","article-title":"Marijuana withdrawal among adults seeking treatment for marijuana dependence","volume":"94","author":"Budney","year":"1999","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.schres.2017.05.006_bb0035","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1037\/0022-006X.68.6.1051","article-title":"Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence","volume":"68","author":"Budney","year":"2000","journal-title":"J. Consult. Clin. Psychol."},{"issue":"3","key":"10.1016\/j.schres.2017.05.006_bb0040","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1037\/0021-843X.112.3.393","article-title":"The time course and significance of cannabis withdrawal","volume":"112","author":"Budney","year":"2003","journal-title":"J. Abnorm. Psychol."},{"issue":"11","key":"10.1016\/j.schres.2017.05.006_bb0045","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1176\/appi.ajp.161.11.1967","article-title":"Review of the validity and significance of cannabis withdrawal syndrome","volume":"161","author":"Budney","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2017.05.006_bb0050","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jsat.2008.01.002","article-title":"Comparison of cannabis and tobacco withdrawal: severity and contribution to relapse","volume":"35","author":"Budney","year":"2008","journal-title":"J. Subst. Abus. Treat."},{"issue":"1","key":"10.1016\/j.schres.2017.05.006_bb0055","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0740-5472(00)00148-3","article-title":"Clinical profile of participants in a brief intervention program for cannabis use disorder","volume":"20","author":"Copeland","year":"2001","journal-title":"J. Subst. Abus. Treat."},{"issue":"5","key":"10.1016\/j.schres.2017.05.006_bb0060","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/clpt.1985.226","article-title":"Excretion patterns of cannabinoid metabolites after last use in a group of chronic users","volume":"38","author":"Ellis","year":"1985","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.schres.2017.05.006_bb0065","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1520\/JFS14636J","article-title":"Potency trends of delta9-THC and other cannabinoids in confiscated marijuana from 1980\u20131997","volume":"45","author":"ElSohly","year":"2000","journal-title":"J. Forensic Sci."},{"issue":"2","key":"10.1016\/j.schres.2017.05.006_bb0070","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1037\/1064-1297.7.2.174","article-title":"Effects of monetary contingencies on smoking relapse: influences of trait depression, personality, and habitual nicotine intake","volume":"7","author":"Gilbert","year":"1999","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"8","key":"10.1016\/j.schres.2017.05.006_bb0075","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/jat\/32.8.562","article-title":"Urinary elimination of 11-nor-9-carboxy-delta9-tetrahydrocannnabinol in cannabis users during continuously monitored abstinence","volume":"32","author":"Goodwin","year":"2008","journal-title":"J. Anal. Toxicol."},{"issue":"3","key":"10.1016\/j.schres.2017.05.006_bb0080","first-page":"257","article-title":"U.S. policy responses to calls for the medical use of cannabis","volume":"88","author":"Hall","year":"2015","journal-title":"Yale J. Biol. Med."},{"issue":"12","key":"10.1016\/j.schres.2017.05.006_bb0085","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1001\/jamapsychiatry.2015.1858","article-title":"Prevalence of marijuana use disorders in the United States between 2001\u20132002 and 2012\u20132013","volume":"72","author":"Hasin","year":"2015","journal-title":"JAMA Psychiat."},{"key":"10.1016\/j.schres.2017.05.006_bb0090","series-title":"Analytical Methodology","first-page":"30","article-title":"Urine testing for drug of abuse","author":"Hawks","year":"1986"},{"issue":"9","key":"10.1016\/j.schres.2017.05.006_bb0095","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","article-title":"The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire","volume":"86","author":"Heatherton","year":"1991","journal-title":"Br. J. Addict."},{"key":"10.1016\/j.schres.2017.05.006_bb0100","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/1471-244X-13-258","article-title":"Time-course of the DSM-5 cannabis withdrawal symptoms in poly-substance abusers","volume":"13","author":"Hesse","year":"2013","journal-title":"BMC Psychiatry"},{"issue":"9","key":"10.1016\/j.schres.2017.05.006_bb0105","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1176\/ajp.148.9.1218","article-title":"A behavioral approach to achieving initial cocaine abstinence","volume":"148","author":"Higgins","year":"1991","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2017.05.006_bb0110","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/jat\/19.6.443","article-title":"Detection times of marijuana metabolites in urine by immunoassay and GC-MS","volume":"19","author":"Huestis","year":"1995","journal-title":"J. Anal. Toxicol."},{"issue":"1","key":"10.1016\/j.schres.2017.05.006_bb0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-3565(25)32251-2","article-title":"Tolerance and disposition of tetrahydrocannabinol in man","volume":"215","author":"Hunt","year":"1980","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.schres.2017.05.006_bb0120","series-title":"Monitoring the Future National Survey Results on Drug use, 1975\u20132011","author":"Johnston","year":"2012"},{"key":"10.1016\/j.schres.2017.05.006_bb0125","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1749-6632.1976.tb49901.x","article-title":"Clinical studies of cannabis tolerance and dependence","volume":"282","author":"Jones","year":"1976","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.schres.2017.05.006_bb0130","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.schres.2017.05.006_bb0135","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/schbul\/sbp031","article-title":"Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis","volume":"36","author":"Koskinen","year":"2010","journal-title":"Schizophr. Bull."},{"issue":"4","key":"10.1016\/j.schres.2017.05.006_bb0140","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1037\/1064-1297.8.4.483","article-title":"Abstinence symptoms during withdrawal from chronic marijuana use","volume":"8","author":"Kouri","year":"2000","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"11","key":"10.1016\/j.schres.2017.05.006_bb0145","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/clinchem\/37.11.1927","article-title":"Importance of creatinine analyses of urine when screening for abused drugs","volume":"37","author":"Lafolie","year":"1991","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.schres.2017.05.006_bb0150","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/0269881111408957","article-title":"Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine","volume":"26","author":"Machielsen","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.schres.2017.05.006_bb0155","series-title":"The Cannabinoids: Chemical, Pharmacologic, and Therapeutic Aspects","first-page":"281","article-title":"Urine excretion patterns of cannabinoids and the clinical application of the EMIT-d.a.u. cannabinoid urine assay for substance abuse treatment","author":"Manno","year":"1984"},{"issue":"Suppl. 2","key":"10.1016\/j.schres.2017.05.006_bb0160","first-page":"3","article-title":"Atypical antipsychotics: sleep, sedation, and efficacy","volume":"6","author":"Miller","year":"2004","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2017.05.006_bb0165","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0376-8716(99)00048-4","article-title":"Hardcore drug users claim to be occasional users: drug use frequency underreporting","volume":"57","author":"Morral","year":"2000","journal-title":"Drug Alcohol Depend."},{"issue":"10","key":"10.1016\/j.schres.2017.05.006_bb0170","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1001\/archpsyc.58.10.909","article-title":"Neuropsychological performance in long-term cannabis users","volume":"58","author":"Pope","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2017.05.006_bb0175","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.schres.2011.02.017","article-title":"The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis","volume":"128","author":"Rabin","year":"2011","journal-title":"Schizophr. Res."},{"issue":"2\u20133","key":"10.1016\/j.schres.2017.05.006_bb0180","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.psychres.2012.11.019","article-title":"Effects of cannabis use status on cognitive function, in males with schizophrenia","volume":"206","author":"Rabin","year":"2013","journal-title":"Psychiatry Res."},{"issue":"2","key":"10.1016\/j.schres.2017.05.006_bb0185","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0379-0738(00)00437-0","article-title":"Time of drug elimination in chronic drug abusers. Case study of 52 patients in a \u201clow-step\u201d detoxification ward","volume":"119","author":"Reiter","year":"2001","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.schres.2017.05.006_bb0190","series-title":"NSDUH Series H-46, Rockville, Maryland","article-title":"Results from the 2012 National Survey on Drug Use and Health: summary of National Findings","author":"SAMHSA","year":"2013"},{"issue":"6","key":"10.1016\/j.schres.2017.05.006_bb0195","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","article-title":"Development of the Alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption\u2013II","volume":"88","author":"Saunders","year":"1993","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.schres.2017.05.006_bb0200","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1521-0391.2014.12126.x","article-title":"Ziprasidone versus clozapine in the treatment of dually diagnosed (DD) patients with schizophrenia and cannabis use disorders: a randomized study","volume":"23","author":"Schnell","year":"2014","journal-title":"Am. J. Addict."},{"issue":"5","key":"10.1016\/j.schres.2017.05.006_bb0205","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1037\/a0029117","article-title":"Residual effects of cannabis use on neurocognitive performance after prolonged abstinence: a meta-analysis","volume":"20","author":"Schreiner","year":"2012","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2017.05.006_bb0210","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.drugalcdep.2016.08.622","article-title":"A contingency management method for 30-days abstinence in non-treatment seeking young adult cannabis users","volume":"167","author":"Schuster","year":"2016","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.schres.2017.05.006_bb0215","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1360-0443.2010.03228.x","article-title":"Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users","volume":"106","author":"Schwilke","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.schres.2017.05.006_bb0220","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jsat.2006.02.001","article-title":"Voucher-based contingent reinforcement of marijuana abstinence among individuals with serious mental illness","volume":"30","author":"Sigmon","year":"2006","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.schres.2017.05.006_bb0225","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1037\/1064-1297.8.4.509","article-title":"Contingent reinforcement of marijuana abstinence among individuals with seriousmental illness: a feasibility study","volume":"8","author":"Sigmon","year":"2000","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.schres.2017.05.006_bb0230","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/jat\/33.4.185","article-title":"Identifying new cannabis use with urine creatinine-normalized THCCOOH concentrations and time intervals between specimen collections","volume":"33","author":"Smith","year":"2009","journal-title":"J. Anal. Toxicol."},{"issue":"5","key":"10.1016\/j.schres.2017.05.006_bb0235","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/jat\/23.5.323","article-title":"Urinary excretion of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and cannabinoids in frequent and infrequent drug users","volume":"23","author":"Smith-Kielland","year":"1999","journal-title":"J. Anal. Toxicol."},{"issue":"4","key":"10.1016\/j.schres.2017.05.006_bb0240","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1360-0443.1988.tb00485.x","article-title":"Reliability of a timeline method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations","volume":"83","author":"Sobell","year":"1988","journal-title":"Br. J. Addict."},{"key":"10.1016\/j.schres.2017.05.006_bb0245","series-title":"World Drug Report 2013","author":"UNODC","year":"2013"},{"key":"10.1016\/j.schres.2017.05.006_bb0250","series-title":"Wechsler Test of Adult Reading","author":"Wechsler","year":"2001"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417302657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417302657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T14:53:08Z","timestamp":1750258388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996417302657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":50,"alternative-id":["S0920996417302657"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2017.05.006","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A method to achieve extended cannabis abstinence in cannabis dependent patients with schizophrenia and non-psychiatric controls","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2017.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}